Probiotics for prevention of necrotising enterocoilitis in preterm neonates.

Phase 4

Recruiting

• Conditions: Other specified diseases of intestine, Preterm newborn1.gestational age 28 to 34 weeks of both genders2.Birth weight of ≤ 2kg or less,

• Registration Number: CTRI/2018/01/011079
• Lead Sponsor: Department of Pediatrics Bhavnagar

Brief Summary

**NECROTIZING ENTEROCOLITIS (NEC) is preterm neonate is a major cause of mortality and morbidity. with the use of probiotics we can minimize the occurrence of****NEC and can reduce subsequent events.i will be choosing high risk  preterm newborns for my study.in 50% of neonate i will be giving probiotics and will keep rest****50% without it and will be studying****occurrence****of changes of NEC in both the groups.**

Detailed Description

Not available

Study Timeline

• Study Start: 2017-09-28
• Last Update Posted: 2019-12-16

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Preterm baby 1.gestational age 28 to 34 weeks 2.Birth weight of ≤ 2kg.

Exclusion Criteria

Preterm newborn 1.Birth weight>2kg 2.Lethal Congenital malformation 3.Newborn on ventilator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
No occurrence of necrotisinig enterocolitis	after 7 days of introducing probiotics

Secondary Outcome Measures

Name	Time	Method
No occurrence of necrotisinig enterocolitis	06 months

Trial Locations

Locations (1)

Sir thakhtsinhji hospital,Bhavnagar; 🇮🇳 Bhavnagar, GUJARAT, India

Sir thakhtsinhji hospital,Bhavnagar

🇮🇳Bhavnagar, GUJARAT, India

Mahendra rathod

Principal investigator

9998042151

dr.mahendrarathod01@gmail.com